Ramirez, Karen Criz .
HRN: 26-99-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2025
CEFUROXIME 1.5GM (VIAL)
04/23/2025
04/24/2025
IV
1.5g
Q8
SP NSVD With RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes